US Stock MarketDetailed Quotes

ACRS Aclaris Therapeutics

Watchlist

1.990
+0.040+2.05%

Close Feb 28 16:00 ET

1.990
0.0000.00%

Post 20:01 ET

214.76MMarket Cap-1.16P/E (TTM)

Aclaris Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aclaris Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 2.700M	--
--	2025/Q1	-- / 2.700M	--
--	2024/Q4	9.211M / 7.041M	--
--	2024/Q3	4.346M / 11.849M	--
--	2024/Q2	2.766M / 1.817M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 2.700M--

--2025/Q1-- / 2.700M--

--2024/Q49.211M / 7.041M--

--2024/Q34.346M / 11.849M--

--2024/Q22.766M / 1.817M--

Unlock Free Earnings Estimates

Open Account

Aclaris Therapeutics Earnings Reports

Aclaris Therapeutics | 10-K: Annual report

Feb 27 16:31 ET

Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update

Feb 27 07:18 ET

Aclaris Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 6, 2024 16:34 ET

Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update

Nov 6, 2024 07:22 ET